RATIONALE: Individuals with sleep-disordered breathing (SDB) are at increased cardiovascular risk, possibly due to SDB-related stresses contributing to atherosclerosis. OBJECTIVES: We postulate that pathways associated with a prothrombotic potential are up-regulated in SDB. METHODS: Morning and evening plasminogen activator inhibitor-1 (PAI-1), morning fibrinogen, and morning D-dimer were measured in 537 Cleveland Family Study adults. Piecewise multivariable linear mixed models estimated relative mean change or mean change in the biomarker per 5-unit increase in apnea-hypopnea index (AHI) in two groups: AHI less than 15 and AHI greater than or equal to 15, and hypoxia defined as percentage of sleep time with Sa(O(2)) less than 90% (< 2%, ≥ 2%). MEASUREMENTS AND MAIN RESULTS: Nonlinear associations were demonstrated: morning and evening PAI-1 increased by 12% (95% confidence interval [CI], 5-20%; P < 0.001) and 11% (95% CI, 2-20%; P = 0.01), respectively per 5-unit AHI increase until an AHI of 15, when no further increase in PAI-1 was demonstrated. The association between AHI and morning PAI-1 remained significant after adjusting for evening PAI-1 level (10%; 95% CI, 3-17%; P < 0.01). Morning fibrinogen increased on average by 8.4 mg/dl (95% CI, 3.12-13.65; P = 0.002) per five-unit AHI increase until an AHI of 15. There was no association between AHI and morning D-dimer. Hypoxia severity was not associated with thrombotic marker levels. CONCLUSIONS: PAI-1 and fibrinogen levels increase monotonically with AHI at degrees of SDB considered mildly to moderately abnormal, suggesting that even mild SDB levels may increase prothrombotic processes. There may be a plateau in this effect, occurring at levels considered to reflect only moderate SDB severity. These relationships with mild-to-moderate SDB were not observed with D-dimer.
RATIONALE: Individuals with sleep-disordered breathing (SDB) are at increased cardiovascular risk, possibly due to SDB-related stresses contributing to atherosclerosis. OBJECTIVES: We postulate that pathways associated with a prothrombotic potential are up-regulated in SDB. METHODS: Morning and evening plasminogen activator inhibitor-1 (PAI-1), morning fibrinogen, and morning D-dimer were measured in 537 Cleveland Family Study adults. Piecewise multivariable linear mixed models estimated relative mean change or mean change in the biomarker per 5-unit increase in apnea-hypopnea index (AHI) in two groups: AHI less than 15 and AHI greater than or equal to 15, and hypoxia defined as percentage of sleep time with Sa(O(2)) less than 90% (< 2%, ≥ 2%). MEASUREMENTS AND MAIN RESULTS: Nonlinear associations were demonstrated: morning and evening PAI-1 increased by 12% (95% confidence interval [CI], 5-20%; P < 0.001) and 11% (95% CI, 2-20%; P = 0.01), respectively per 5-unit AHI increase until an AHI of 15, when no further increase in PAI-1 was demonstrated. The association between AHI and morning PAI-1 remained significant after adjusting for evening PAI-1 level (10%; 95% CI, 3-17%; P < 0.01). Morning fibrinogen increased on average by 8.4 mg/dl (95% CI, 3.12-13.65; P = 0.002) per five-unit AHI increase until an AHI of 15. There was no association between AHI and morning D-dimer. Hypoxia severity was not associated with thrombotic marker levels. CONCLUSIONS:PAI-1 and fibrinogen levels increase monotonically with AHI at degrees of SDB considered mildly to moderately abnormal, suggesting that even mild SDB levels may increase prothrombotic processes. There may be a plateau in this effect, occurring at levels considered to reflect only moderate SDB severity. These relationships with mild-to-moderate SDB were not observed with D-dimer.
Authors: N Ohkura; K Oishi; N Fukushima; M Kasamatsu; G-I Atsumi; N Ishida; S Horie; J Matsuda Journal: J Thromb Haemost Date: 2006-09-13 Impact factor: 5.824
Authors: H Klar Yaggi; John Concato; Walter N Kernan; Judith H Lichtman; Lawrence M Brass; Vahid Mohsenin Journal: N Engl J Med Date: 2005-11-10 Impact factor: 91.245
Authors: Reena Mehra; Amy Storfer-Isser; H Lester Kirchner; Nathan Johnson; Nancy Jenny; Russell P Tracy; Susan Redline Journal: Arch Intern Med Date: 2006-09-18
Authors: D J Pinsky; H Liao; C A Lawson; S F Yan; J Chen; P Carmeliet; D J Loskutoff; D M Stern Journal: J Clin Invest Date: 1998-09-01 Impact factor: 14.808
Authors: S Javaheri; T J Parker; J D Liming; W S Corbett; H Nishiyama; L Wexler; G A Roselle Journal: Circulation Date: 1998-06-02 Impact factor: 29.690
Authors: Lu-Chen Weng; Weihong Tang; Stephen S Rich; Nicholas L Smith; Susan Redline; Christopher J O'Donnell; Saonli Basu; Alexander P Reiner; Joseph A Delaney; Russell P Tracy; Cameron D Palmer; Taylor Young; Qiong Yang; Aaron R Folsom; Mary Cushman Journal: Thromb Res Date: 2014-05-20 Impact factor: 3.944
Authors: Zehra Tosur; David Green; Peter John De Chavez; Kristen L Knutson; Jeffrey J Goldberger; Phyllis Zee; Kiang Liu; Kwang-Youn Kim; Mercedes R Carnethon Journal: Sleep Med Date: 2014-04-30 Impact factor: 3.492
Authors: Roland von Känel; Loki Natarajan; Sonia Ancoli-Israel; Paul J Mills; Tanya Wolfson; Anthony C Gamst; José S Loredo; Joel E Dimsdale Journal: Sleep Med Date: 2012-10-01 Impact factor: 3.492
Authors: Fadi Seif; Sanjay R Patel; Harneet Walia; Michael Rueschman; Deepak L Bhatt; Daniel J Gottlieb; Eldrin F Lewis; Susheel P Patil; Naresh M Punjabi; Denise C Babineau; Susan Redline; Reena Mehra Journal: J Sleep Res Date: 2013-01-19 Impact factor: 3.981
Authors: Jingjing Liang; Brian E Cade; Heming Wang; Han Chen; Kevin J Gleason; Emma K Larkin; Richa Saxena; Xihong Lin; Susan Redline; Xiaofeng Zhu Journal: Genet Epidemiol Date: 2016-04 Impact factor: 2.135
Authors: Henry Blomster; Tomi Laitinen; Tiina Lyyra-Laitinen; Esko Vanninen; Helena Gylling; Markku Peltonen; Tarja Martikainen; Johanna Sahlman; Jouko Kokkarinen; Jukka Randell; Grigori Smirnov; Juha Seppä; Henri Tuomilehto Journal: Sleep Breath Date: 2013-06-04 Impact factor: 2.816